RSCM
NUVB icon

Rock Springs Capital Management’s Nuvation Bio NUVB Stock Holding History

Rock Springs Capital Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-236,609
Closed -$2.35M – 145
2021
Q3 		$2.35M Sell
236,609
-4,876
-2% -$44.2K 0.05% 139
2021
Q2 		$2.25M Sell
241,485
-160,603
-40% -$1.83M 0.04% 143
2021
Q1 		$4.2M Buy
+402,088
New +$4.5M 0.09% 133

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

Rock Springs Capital Management's NUVB Position: Q4 2021 in Review

Rock Springs Capital Management sold out of Nuvation Bio (NUVB) in Q4 2021, closing a stake of 236,609 shares — an estimated $2.35M sold.

Rock Springs Capital Management first reported a position in NUVB in Q1 2021 and held it in 3 quarters. The position peaked at $4.2M in Q1 2021. 105 funds tracked by Wall St. Rank hold NUVB as of Q4 2021.

  • Rock Springs Capital Management reported no remaining Nuvation Bio position as of Q4 2021 after selling out during the quarter.
  • Rock Springs Capital Management sold 236,609 Nuvation Bio shares in Q4 2021, an estimated $2.35M.
  • Rock Springs Capital Management first reported a position in Nuvation Bio in Q1 2021 and held it in 3 quarters.
  • Rock Springs Capital Management's Nuvation Bio position peaked at $4.2M in Q1 2021.
  • 105 funds tracked by Wall St. Rank held Nuvation Bio as of Q4 2021.

Based on Rock Springs Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.